These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15312501)

  • 1. [Taking vulnerable plaque away, eradicating heart attack].
    Zhang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1057-61. PubMed ID: 15312501
    [No Abstract]   [Full Text] [Related]  

  • 2. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arithmetic of vulnerable plaques for noninvasive imaging.
    Narula J; Garg P; Achenbach S; Motoyama S; Virmani R; Strauss HW
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S2-10. PubMed ID: 18641603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emperor's clothes: in search of the vulnerable plaque.
    Kereiakes DJ
    Circulation; 2003 Apr; 107(16):2076-7. PubMed ID: 12719288
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a vulnerable plaque?
    Maseri A; Fuster V
    Circulation; 2003 Apr; 107(16):2068-71. PubMed ID: 12719286
    [No Abstract]   [Full Text] [Related]  

  • 6. Animal models and potential mechanisms of plaque destabilisation and disruption.
    Ni M; Chen WQ; Zhang Y
    Heart; 2009 Sep; 95(17):1393-8. PubMed ID: 19153105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise and the risk of sudden cardiac death.
    Corrado D; Migliore F; Basso C; Thiene G
    Herz; 2006 Sep; 31(6):553-8. PubMed ID: 17036186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safeguarding against the exercise paradox.
    Johns Hopkins Med Lett Health After 50; 2003 Mar; 15(1):8. PubMed ID: 12703448
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary atherosclerosis in sudden cardiac death: an autopsy study.
    Sudha ML; Sundaram S; Purushothaman KR; Kumar PS; Prathiba D
    Indian J Pathol Microbiol; 2009; 52(4):486-9. PubMed ID: 19805952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery disease and prevention of heart failure.
    Klein L; Gheorghiade M
    Med Clin North Am; 2004 Sep; 88(5):1209-35. PubMed ID: 15331314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The athlete's heart: prevention of sudden cardiac death.
    Manshadi R
    Rev Cardiovasc Med; 2008; 9(4):259-60. PubMed ID: 19122583
    [No Abstract]   [Full Text] [Related]  

  • 12. Progression of subclinical coronary atherosclerosis: does obesity make a difference?
    Cassidy AE; Bielak LF; Zhou Y; Sheedy PF; Turner ST; Breen JF; Araoz PA; Kullo IJ; Lin X; Peyser PA
    Circulation; 2005 Apr; 111(15):1877-82. PubMed ID: 15837939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of coronary calcification in asymptomatic persons].
    Möhlenkamp S; Erbel R
    MMW Fortschr Med; 2007 Apr; 149(14):38-40. PubMed ID: 17668761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
    Struthers AD
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):211-4. PubMed ID: 11881125
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden death associated with anomalous coronary origin and obstructive coronary disease in the young.
    Eckart RE; Jones SO; Shry EA; Garrett PD; Scoville SL
    Cardiol Rev; 2006; 14(4):161-3. PubMed ID: 16788326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navigating the crossroads of coronary artery disease and heart failure.
    Gheorghiade M; Sopko G; De Luca L; Velazquez EJ; Parker JD; Binkley PF; Sadowski Z; Golba KS; Prior DL; Rouleau JL; Bonow RO
    Circulation; 2006 Sep; 114(11):1202-13. PubMed ID: 16966596
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of methodology: how should we define left ventricular hypertrophy?
    Gondoni LA
    Am J Cardiol; 2009 Feb; 103(4):574. PubMed ID: 19195524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alpha-linolenic acid, cardiovascular disease and sudden death].
    Landmark K; Alm CS
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2792-4. PubMed ID: 17086218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerable plaque paradigm: prediction of future clinical events based on a morphological definition.
    Granada JF; Kaluza GL; Raizner AE; Moreno PR
    Catheter Cardiovasc Interv; 2004 Jul; 62(3):364-74. PubMed ID: 15224306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.